Epidermal growth factor—induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products

This publication has 30 references indexed in Scilit:

• Characterization of tetramethylrhodaminyl‐phalloidin binding to cellular F‐actin
  Cell Motility, 1992
• Modulation of phospholipase A2 activity by epidermal growth factor (EGF) in CHO cells transfected with human EGF receptor. Role of receptor cytoplasmic subdomain
  Biochemical Journal, 1991
• Lack of correlation between changes in polyphosphoinositide levels and actin/gelsolin complexes in A431 cells treated with epidermal growth factor.
  The Journal of cell biology, 1991
• Actin assembly in electropermeabilized neutrophils: role of intracellular calcium.
  The Journal of cell biology, 1990
• Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
  Nature, 1990
• L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor
  Canadian Journal of Physiology and Pharmacology, 1989
• Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor.
  The Journal of cell biology, 1989
• RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENS
  Annual Review of Biochemistry, 1987
• Rapid induction of morphological changes in human carcinoma cells A-431 by epidermal growth factors.
  The Journal of cell biology, 1979
• The Dissociation of the Phalloidin-Actin Complex
  Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1977